Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 247218, 8 pages
http://dx.doi.org/10.1155/2014/247218
Review Article

Methodological Issues and Evidence of Malfeasance in Research Purporting to Show Thimerosal in Vaccines Is Safe

1Simpson University, 2211 College View Drive, Redding, CA 96001, USA
2Institute of Chronic Illness, Inc., 14 Redgate Court, Silver Spring, MD 20905, USA
3University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75235, USA
4University of Kentucky, Lexington, KY 40506, USA
5CoMeD, Inc., Silver Spring, MD, USA

Received 15 February 2014; Accepted 12 May 2014; Published 4 June 2014

Academic Editor: Jyutika Mehta

Copyright © 2014 Brian Hooker et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. G. Dórea, “Low-dose mercury exposure in early life: relevance of thimerosal to fetuses, newborns and infants,” Current Medicinal Chemistry, vol. 20, no. 32, pp. 4060–4069, 2013. View at Publisher · View at Google Scholar
  2. D. A. Geier, L. K. Sykes, and M. R. Geier, “A review of thimerosal (merthiolate) and its ethylmercury breakdown product: specific historical considerations regarding safety and effectiveness,” Journal of Toxicology and Environmental Health B: Critical Reviews, vol. 10, no. 8, pp. 575–596, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. D. G. Fagan, J. S. Pritchard, T. W. Clarkson, and M. R. Greenwood, “Organ mercury levels in infants with omphaloceles treated with organic mercurial antiseptic,” Archives of Disease in Childhood, vol. 52, no. 12, pp. 962–964, 1977. View at Google Scholar · View at Scopus
  4. D. S. Matheson, T. W. Clarkson, and E. W. Gelfand, “Mercury toxicity (acrodynia) induced by long-term injection of gammaglobulin,” Journal of Pediatrics, vol. 97, no. 1, pp. 153–155, 1980. View at Google Scholar · View at Scopus
  5. J. H. Axton, “Six cases of poisoning after a parenteral organic mercurial compound (merthiolate),” Postgraduate Medical Journal, vol. 48, no. 561, pp. 417–421, 1972. View at Google Scholar · View at Scopus
  6. A. Patrizi, L. Rizzoli, C. Vincenzi, P. Trevisi, and A. Tosti, “Sensitization to thimerosal in atopic children,” Contact Dermatitis, vol. 40, no. 2, pp. 94–97, 1999. View at Publisher · View at Google Scholar · View at Scopus
  7. O. P. Heinonen, S. Shapiro, R. R. Monson, S. C. Hartz, L. Rosenberg, and D. Slone, “Immunization during pregnancy against poliomyelitis and influenza in relation to childhood malignancy,” International Journal of Epidemiology, vol. 2, no. 3, pp. 229–235, 1973. View at Google Scholar · View at Scopus
  8. A. Vojdani, J. B. Pangborn, E. Vojdani, and E. L. Cooper, “Infections, toxic chemicals and dietary peptides binding to lymphocyte receptors and tissue enzymes are major instigators of autoimmunity in autism,” International Journal of Immunopathology and Pharmacology, vol. 16, no. 3, pp. 189–199, 2003. View at Google Scholar · View at Scopus
  9. K. J. Koh, L. Warren, L. Moore, C. James, and G. N. Thompson, “Wells' syndrome following thiomersal-containing vaccinations,” Australasian Journal of Dermatology, vol. 44, no. 3, pp. 199–202, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. H. A. Young, D. A. Geier, and M. R. Geier, “Thimerosal exposure in infants and neurodevelopmental disorders: an assessment of computerized medical records in the vaccine safety datalink,” Journal of the Neurological Sciences, vol. 271, no. 1-2, pp. 110–118, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Gallagher and M. Goodman, “Hepatitis B triple series vaccine and developmental disability in US children aged 1–9 years,” Toxicological and Environmental Chemistry, vol. 90, no. 5, pp. 997–1008, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. D. Mrozek-Budzyn, R. Majewska, A. Kieltyka, and M. Augustyniak, “Neonatal exposure to thimerosal from vaccines and child development in the first 3 years of life,” Neurotoxicology and Teratology, vol. 34, no. 6, pp. 592–597, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. J. G. Dórea, R. C. Marques, and C. Isejima, “Neurodevelopment of Amazonian infants: antenatal and postnatal exposure to methyl- and ethylmercury,” Journal of Biomedicine and Biotechnology, vol. 2012, Article ID 132876, 9 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. D. A. Geier, B. S. Hooker, J. K. Kern, P. G. King, L. K. Sykes, and M. R. Geier, “A two-phase study evaluating the relationship between thimerosal-containing vaccine administration and the risk for an autism spectrum disorder diagnosis in the united states,” Translational Neurodegeneration, vol. 2, article 25, 2013. View at Publisher · View at Google Scholar
  15. C. M. Gallagher and M. S. Goodman, “Hepatitis B vaccination of male neonates and autism diagnosis, NHIS 1997–2002,” Journal of Toxicology and Environmental Health A: Current Issues, vol. 73, no. 24, pp. 1665–1677, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. D. A. Geier, P. G. King, L. K. Sykes, and M. R. Geier, “A comprehensive review of mercury provoked autism,” Indian Journal of Medical Research, vol. 128, no. 4, pp. 383–411, 2008. View at Google Scholar · View at Scopus
  17. J. P. Barile, G. P. Kuperminc, E. S. Weintraub, J. W. Mink, and W. W. Thompson, “Thimerosal exposure in early life and neuropsychological outcomes 7–10 years later,” Journal of Pediatric Psychology, vol. 37, no. 1, pp. 106–118, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. D. A. Geier and M. R. Geier, “A meta-analysis epidemiological assessment of neurodevelopmental disorders following vaccines administered from 1994 through 2000 in the United States,” Neuroendocrinology Letters, vol. 27, no. 4, pp. 401–413, 2006. View at Google Scholar · View at Scopus
  19. Immunization Safety and Autism, http://www.cdc.gov/vaccinesafety/00_pdf/CDCStudiesonVaccinesandAutism.pdf.
  20. T. Verstraeten, R. L. Davis, D. Gu, and F. DeStefano, “Increased risk of developmental neurologic impairment after high exposure to thimerosal-containing vaccine in first month of life,” in Proceedings of the Epidemic Intelligence Service Annual Conference, vol. 49, Centers for Disease Control and Prevention, Atlanta, Ga, USA, 2000.
  21. K. M. Madsen, M. B. Lauritsen, C. B. Pedersen et al., “Thimerosal and the occurrence of autism: negative ecological evidence from Danish population-based data,” Pediatrics, vol. 112, no. 3 I, pp. 604–606, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. P. Stehr-Green, P. Tull, M. Stellfeld, P.-B. Mortenson, and D. Simpson, “Autism and thimerosal-containing vaccines: lack of consistent evidence for an association,” American Journal of Preventive Medicine, vol. 25, no. 2, pp. 101–106, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Hviid, M. Stellfeld, J. Wohlfahrt, and M. Melbye, “Association between thimerosal-containing vaccine and autism,” Journal of the American Medical Association, vol. 290, no. 13, pp. 1763–1766, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. N. Andrews, E. Miller, A. Grant, J. Stowe, V. Osborne, and B. Taylor, “Thimerosal exposure in infants and developmental disorders: a retrospective cohort study in the United Kingdom does not support a causal association,” Pediatrics, vol. 114, no. 3, pp. 584–591, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. T. Verstraeten, R. L. Davis, F. DeStefano et al., “Safety of thimerosal-containing vaccines: a two-phased study of computerized health maintenance organization databases,” Pediatrics, vol. 112, no. 5, pp. 1039–1048, 2003. View at Google Scholar · View at Scopus
  26. C. S. Price, W. W. Thompson, B. Goodson et al., “Prenatal and infant exposure to thimerosal from vaccines and immunoglobulins and risk of autism,” Pediatrics, vol. 126, no. 4, pp. 656–664, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. K. M. Madsen, A. Hviid, M. Vestergaard et al., “MMR vaccination and autism–a population-based follow-up study,” Ugeskrift for Laeger, vol. 164, no. 49, pp. 5741–5744, 2002. View at Google Scholar · View at Scopus
  28. B. S. Hooker and J. A. Trelka, “More on Madsen's analysis,” Journal of American Physicians and Surgeons, vol. 9, no. 4, 2004. View at Google Scholar
  29. T. K. Gronborg, D. E. Schendel, and E. T. Parner, “Recurrence of autism spectrum disorders in full- and half-siblings and trends over time: a population-based cohort study,” Journal of the American Medical Association Pediatrics, vol. 167, no. 10, pp. 947–953, 2013. View at Publisher · View at Google Scholar
  30. M. F. Blaxill, “The rising incidence of autism: associations with thimerosal,” in Immunization Safety Review: Thimerosal-Containing Vaccines and Neurodevelopmental Disorders, Institute of Medicine, Washington, DC, USA, 2001. View at Google Scholar
  31. M. F. Blaxill and P. Stehr-Green, “Concerns continue over mercury and autism (multiple letters),” American Journal of Preventive Medicine, vol. 26, no. 1, pp. 91–92, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. M. C. DeSoto and R. T. Hitlan, “Vaccine safety study as an interesting case of “over-matching”,” in Recent Advances in Autism Spectrum Disorders—Volume I, M. Fitzgerald, Ed., P.M.F., 2013. View at Publisher · View at Google Scholar
  33. C. Price, A. Robertson, and B. Goodson, Thimerosal and Autism, ABT Associates, 2009.
  34. W. W. Thompson, C. Price, B. Goodson et al., “Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years,” The New England Journal of Medicine, vol. 357, no. 13, pp. 1281–1292, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. D. A. Geier and M. R. Geier, “A two-phased population epidemiological study of the safety of thimerosal-containing vaccines: a follow-up analysis,” Medical Science Monitor, vol. 11, no. 4, pp. CR160–CR170, 2005. View at Google Scholar · View at Scopus